Challenging the status quo: ivonescimab’s bid to displace anti-PD-(L)1 inhibitors

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/1CD3B057.svg?ark=w1%2F20260521%2F1CD3B057&value=id)](https://nobleid.org/work/w1/20260521/1CD3B057)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors